ATE245440T1 - Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs - Google Patents

Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs

Info

Publication number: ATE245440T1
Authority: AT; Austria
Prior art keywords: topotecan; cancer; prevention; treatment; composition containing
Prior art date: 1998-05-21

Application number

AT99952068T

Other languages

English (en)

Inventor

Randall K Johnson

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-21

Filing date

1999-05-20

Publication date

2003-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22199389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE245440(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-05-20 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2003-08-15 Application granted granted Critical

2003-08-15 Publication of ATE245440T1 publication Critical patent/ATE245440T1/de

Links

206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
230000002265 prevention Effects 0.000 title 1
UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 title 1
229960000303 topotecan Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

AT99952068T 1998-05-21 1999-05-20 Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs ATE245440T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8656098P	1998-05-21	1998-05-21
PCT/US1999/011160 WO1999059565A1 (en)	1998-05-21	1999-05-20	Novel compositions

Publications (1)

Publication Number	Publication Date
ATE245440T1 true ATE245440T1 (de)	2003-08-15

Family

ID=22199389

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99952068T ATE245440T1 (de)	1998-05-21	1999-05-20	Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs

Country Status (27)

Country	Link
US (1)	US6582689B1 (de)
EP (1)	EP1079818B1 (de)
JP (1)	JP4283998B2 (de)
KR (1)	KR100624588B1 (de)
CN (1)	CN1227027C (de)
AR (1)	AR019844A1 (de)
AT (1)	ATE245440T1 (de)
AU (1)	AU750918B2 (de)
BR (1)	BR9910622A (de)
CA (1)	CA2328603A1 (de)
CO (1)	CO5050337A1 (de)
CZ (1)	CZ300496B6 (de)
DE (1)	DE69909781T2 (de)
DK (1)	DK1079818T3 (de)
ES (1)	ES2204164T3 (de)
GC (1)	GC0000102A (de)
HU (1)	HUP0600520A2 (de)
IL (2)	IL139733A0 (de)
MY (1)	MY123434A (de)
NO (1)	NO329195B1 (de)
NZ (1)	NZ508115A (de)
PL (1)	PL200840B1 (de)
PT (1)	PT1079818E (de)
TR (1)	TR200003453T2 (de)
TW (1)	TWI227136B (de)
WO (1)	WO1999059565A1 (de)
ZA (1)	ZA200006675B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2004530432A (ja)	2001-03-08	2004-10-07	アレス・トレーディング・ソシエテ・アノニム	インターロイキン−１８変異体、その産生および使用
US20050079153A1 (en) *	2002-08-14	2005-04-14	Pfizer Inc.	Methods for enhancing immune functions in neonatal mammals by administration of IL-18
AU2003295331A1 (en) *	2002-09-19	2004-04-23	Centocor, Inc.	Method of inducing maturation of dendritic cells and uses therefor
ATE526057T1 (de) *	2004-08-20	2011-10-15	Glaxosmithkline Llc	Wundheilung durch verabreichung von menschlichem il-18
US20100061958A1 (en)	2006-09-14	2010-03-11	The Trustees Of The University Of Pennsylvania	Modulation of Regulatory T Cells by Human IL-18
AR065803A1 (es) *	2007-03-23	2009-07-01	Smithkline Beecham Corp	Uso de un polipeptido de il- 18 humana y un anticuerpo anti- cd para preparar unmedicamento
GB0803352D0 (en)	2008-02-22	2008-04-02	Ntnu Technology Transfer As	Oligopeptidic compounds and uses thereof
US8168165B2 (en) *	2008-12-23	2012-05-01	Abbott Laboratories	Alkylated interleukin-18 compositions
TW201506402A (zh) *	2013-08-15	2015-02-16	Tonyar Biotech Inc	自體防潮的檢驗芯片及其製造方法
JP7795181B2 (ja)	2017-09-06	2026-01-07	イェールユニバーシティー	インターロイキン－１８バリアントとその利用法
KR20230117120A (ko)	2020-11-02	2023-08-07	심카 아이엘-18, 인크.	인터류킨-18 변이체 및 사용 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2697752B1 (fr) *	1992-11-10	1995-04-14	Rhone Poulenc Rorer Sa	Compositions antitumorales contenant des dérivés du taxane.
TW581771B (en) *	1994-11-15	2004-04-01	Hayashibara Biochem Lab	Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
JP4004088B2 (ja) *	1995-09-26	2007-11-07	株式会社林原生物化学研究所	免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US6207641B1 (en) *	1995-03-10	2001-03-27	Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo	Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5869535A (en) *	1995-03-21	1999-02-09	The Board Of Trustees Of The University Of Illinois	Method and composition for selectively inhibiting melanoma
JP4024366B2 (ja)	1996-11-29	2007-12-19	株式会社林原生物化学研究所	ポリペプチド

1999
- 1999-05-17 TW TW088107944A patent/TWI227136B/zh not_active IP Right Cessation
- 1999-05-19 GC GCP1999159 patent/GC0000102A/xx active
- 1999-05-19 MY MYPI99001971A patent/MY123434A/en unknown
- 1999-05-20 CO CO99030928A patent/CO5050337A1/es unknown
- 1999-05-20 AT AT99952068T patent/ATE245440T1/de active IP Right Revival
- 1999-05-20 CA CA002328603A patent/CA2328603A1/en not_active Abandoned
- 1999-05-20 HU HU0600520A patent/HUP0600520A2/hu unknown
- 1999-05-20 AR ARP990102416A patent/AR019844A1/es active IP Right Grant
- 1999-05-20 DE DE69909781T patent/DE69909781T2/de not_active Expired - Lifetime
- 1999-05-20 WO PCT/US1999/011160 patent/WO1999059565A1/en not_active Ceased
- 1999-05-20 EP EP99952068A patent/EP1079818B1/de not_active Expired - Lifetime
- 1999-05-20 PL PL366170A patent/PL200840B1/pl not_active IP Right Cessation
- 1999-05-20 NZ NZ508115A patent/NZ508115A/en not_active IP Right Cessation
- 1999-05-20 KR KR1020007013014A patent/KR100624588B1/ko not_active Expired - Fee Related
- 1999-05-20 CN CNB998089842A patent/CN1227027C/zh not_active Expired - Fee Related
- 1999-05-20 ES ES99952068T patent/ES2204164T3/es not_active Expired - Lifetime
- 1999-05-20 TR TR2000/03453T patent/TR200003453T2/xx unknown
- 1999-05-20 US US09/700,609 patent/US6582689B1/en not_active Expired - Fee Related
- 1999-05-20 DK DK99952068T patent/DK1079818T3/da active
- 1999-05-20 AU AU43094/99A patent/AU750918B2/en not_active Ceased
- 1999-05-20 CZ CZ20004321A patent/CZ300496B6/cs not_active IP Right Cessation
- 1999-05-20 IL IL13973399A patent/IL139733A0/xx unknown
- 1999-05-20 PT PT99952068T patent/PT1079818E/pt unknown
- 1999-05-20 BR BR9910622-1A patent/BR9910622A/pt not_active Application Discontinuation
- 1999-05-20 JP JP2000549230A patent/JP4283998B2/ja not_active Expired - Fee Related
2000
- 2000-11-15 ZA ZA200006675A patent/ZA200006675B/en unknown
- 2000-11-16 IL IL139733A patent/IL139733A/en not_active IP Right Cessation
- 2000-11-20 NO NO20005857A patent/NO329195B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL139733A0 (en)	2002-02-10
TWI227136B (en)	2005-02-01
EP1079818A4 (de)	2001-12-12
KR100624588B1 (ko)	2006-09-18
NO329195B1 (no)	2010-09-13
NO20005857D0 (no)	2000-11-20
CN1227027C (zh)	2005-11-16
PT1079818E (pt)	2004-02-27
CO5050337A1 (es)	2001-06-27
IL139733A (en)	2009-06-15
BR9910622A (pt)	2001-01-30
GC0000102A (en)	2005-06-29
CZ300496B6 (cs)	2009-06-03
DE69909781T2 (de)	2004-05-27
CZ20004321A3 (en)	2001-05-16
DE69909781D1 (de)	2003-08-28
PL200840B1 (pl)	2009-02-27
AU750918B2 (en)	2002-08-01
HUP0600520A2 (en)	2006-10-28
KR20010052369A (ko)	2001-06-25
DK1079818T3 (da)	2004-04-19
CA2328603A1 (en)	1999-11-25
US6582689B1 (en)	2003-06-24
JP2003509333A (ja)	2003-03-11
AR019844A1 (es)	2002-03-20
TR200003453T2 (tr)	2001-10-22
AU4309499A (en)	1999-12-06
EP1079818A1 (de)	2001-03-07
NZ508115A (en)	2003-12-19
JP4283998B2 (ja)	2009-06-24
WO1999059565A1 (en)	1999-11-25
HK1035136A1 (en)	2001-11-16
MY123434A (en)	2006-05-31
CN1367686A (zh)	2002-09-04
NO20005857L (no)	2000-11-21
EP1079818B1 (de)	2003-07-23
ZA200006675B (en)	2002-02-27
PL366170A1 (en)	2005-01-24
ES2204164T3 (es)	2004-04-16

Legal Events

Date

Code

Title

Description

2004-01-15

RER

Ceased as to paragraph 5 lit. 3 law introducing patent treaties

2004-03-15

EEWE

Authorization for restitution

2004-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1079818

Country of ref document: EP

Publication	Publication Date	Title
DE69942680D1 (de)	2010-09-23	Verfahren und Zusammensetzungen zur Prävention und Behandlung von Anämie
EP1085892A4 (de)	2002-07-17	Impfstrategie zur vorbeugung und behandlung von krebs
ATE363904T1 (de)	2007-06-15	Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs
ATE265857T1 (de)	2004-05-15	Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
AU6147401A (en)	2001-11-26	Compositions and methods for the treatment of cancer
EP1231887A4 (de)	2009-08-05	Methode und zusammensetzung zur behandlung von narben
BR9508886A (pt)	1997-12-30	Compostos e métodos para o tratamento de câncer
DE69404384D1 (de)	1997-09-04	Mittel zur Oberflächenbehandlung von Kupfer und Kupferlegierungen
AU2212299A (en)	1999-07-26	Compositions and methods for the treatment of tumor
DE69812784D1 (de)	2003-05-08	Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
HUP0104688A3 (en)	2004-07-28	Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
KR100510795B1 (en)	2005-08-30	Compositions and Methods for the Treatment of Tumor
DE60030554T8 (de)	2008-01-10	Verwendungen von et743 zur behandlung von krebs
ATE414512T1 (de)	2008-12-15	Kombinationstherapie zur behandlung von krebs
NZ514044A (en)	2001-09-28	Herbal compositions and uses for the treatment of allergic reactions
DE69714862D1 (de)	2002-09-26	Lösungen und verfahren zur oberblächenbehandlung von metallen
DE50213690D1 (de)	2009-08-27	Verfahren zur charakterisierung und/oder identifizierung von wirkmechanismen antimikrobieller prüfsubstanzen
DE69909781D1 (de)	2003-08-28	Zusammensetzung enthaltend il-18 und topotecan zur behandulung und/oder vorbeugung von krebs
DE60002226D1 (de)	2003-05-22	Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte
IL158206A0 (en)	2004-05-12	Compositions and methods for the prevention and treatment of human prostate cancer
IL143212A0 (en)	2002-04-21	Compositions and methods for the treatment of tumor
IL141426A0 (en)	2002-03-10	Compositions and methods for the treatment of tumor
NO994631D0 (no)	1999-09-23	Fremgangsmaater og sammensetninger for behandling av eggstokkreft
PL368035A1 (en)	2005-03-21	Compositions and methods for the treatment of cancer
NO20001758D0 (no)	2000-04-05	Fremgangsmåter og blandinger for behandling av leddgikt